Pharmacological Modulation of Cocaine Effects - 1
2 other identifiers
interventional
N/A
1 country
1
Brief Summary
The purpose of this study is to conduct human laboratory studies of possible cocaine interactions with various potential treatment medications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 20, 1999
CompletedFirst Posted
Study publicly available on registry
September 21, 1999
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2001
CompletedJanuary 12, 2017
October 1, 2016
September 20, 1999
January 11, 2017
Conditions
Keywords
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- National Institute on Drug Abuse (NIDA)lead
- Johns Hopkins Universitycollaborator
Study Sites (1)
Johns Hopkins University (BPRU) Bayview Campus
Baltimore, Maryland, 21224 6823, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
George Bigelow, Ph.D.
Johns Hopkins University
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Purpose
- TREATMENT
- Sponsor Type
- NIH
Study Record Dates
First Submitted
September 20, 1999
First Posted
September 21, 1999
Study Completion
December 1, 2001
Last Updated
January 12, 2017
Record last verified: 2016-10